Amrize’s attempt to secure higher valuations in the U.S. market through a spin-off from its Swiss parent, Holcim, has not materialized as anticipated. Despite the company’s U.S. listing, its stock performance has lagged behind expectations, contrasting with Holcim’s robust results in Europe. Analysts note that Amrize’s operational performance has been slower than initially projected, particularly in residential construction, where high interest rates and elevated transport costs have dampened demand. Unlike Holcim, Amrize has struggled to pass on price increases to customers, partly due to rising logistics expenses, which have surged by 100 to 200 percent. The U.S. administration’s lack of targeted support for the sector has further hindered growth, according to analysts from Vontobel and ZKB.
Amrize’s US Listing Struggles as Holcim Leads European Baustoff Sector
Amrize’s separation from Holcim and U.S. listing failed to deliver expected valuation gains, while Holcim outperformed peers with strong operational results and market recognition.
PA
Priya Anand · Equities & Earnings Desk · 14 Sept 2026 · 02:44 · 1 Min. Lesezeit
Dieser Artikel wurde mit KI-Unterstützung erstellt und von einer Finances-Review-Redakteurin bearbeitet.
ADVERTISEMENT

PA
Geschrieben von
Priya Anand
Equities & Earnings Desk
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
Mehr von Priya Anand →









